Maternal Folate Status and the BHMT c.716G>A Polymorphism Affect the Betaine Dimethylglycine Pathway during Pregnancy

The effect of the betaine: homocysteine methyltransferase BHMT c.716G>A (G: guanosine; A: adenosine) single nucleotide polymorphism (SNP) on the BHMT pathway is unknown during pregnancy. We hypothesised that it impairs betaine to dimethylglycine conversion and that folate status modifies its...

Full description

Bibliographic Details
Main Authors: Jose M. Colomina, Pere Cavallé-Busquets, Sílvia Fernàndez-Roig, Pol Solé-Navais, Joan D. Fernandez-Ballart, Mónica Ballesteros, Per M. Ueland, Klaus Meyer, Michelle M. Murphy
Format: Article
Language:English
Published: MDPI AG 2016-10-01
Series:Nutrients
Subjects:
A
Online Access:http://www.mdpi.com/2072-6643/8/10/621
id doaj-54cdb05a643041dea18ca89450f85ded
record_format Article
spelling doaj-54cdb05a643041dea18ca89450f85ded2020-11-25T00:49:06ZengMDPI AGNutrients2072-66432016-10-0181062110.3390/nu8100621nu8100621Maternal Folate Status and the BHMT c.716G>A Polymorphism Affect the Betaine Dimethylglycine Pathway during PregnancyJose M. Colomina0Pere Cavallé-Busquets1Sílvia Fernàndez-Roig2Pol Solé-Navais3Joan D. Fernandez-Ballart4Mónica Ballesteros5Per M. Ueland6Klaus Meyer7Michelle M. Murphy8Area of Preventive Medicine and Public Health, Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili, IISPV, C/Sant Llorenç 21, Reus 43201, SpainCiberobn Fisiopatología de la Obesidad y Nutrición (CB06/03), Instituto Carlos III, Madrid 28029, SpainArea of Preventive Medicine and Public Health, Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili, IISPV, C/Sant Llorenç 21, Reus 43201, SpainArea of Preventive Medicine and Public Health, Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili, IISPV, C/Sant Llorenç 21, Reus 43201, SpainArea of Preventive Medicine and Public Health, Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili, IISPV, C/Sant Llorenç 21, Reus 43201, SpainArea of Obstetrics and Gynaecology, Hospital Universitari Joan XXIII, Tarragona and Universitat Rovira i Virgili, Tarragona 43005, SpainSection for Pharmacology, Department of Internal Medicine, University of Bergen, Bergen N-5020, NorwayBevital A/S, Laboratory building, 9th floor, Bergen N-5021, NorwayArea of Preventive Medicine and Public Health, Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili, IISPV, C/Sant Llorenç 21, Reus 43201, SpainThe effect of the betaine: homocysteine methyltransferase BHMT c.716G>A (G: guanosine; A: adenosine) single nucleotide polymorphism (SNP) on the BHMT pathway is unknown during pregnancy. We hypothesised that it impairs betaine to dimethylglycine conversion and that folate status modifies its effect. We studied 612 women from the Reus Tarragona Birth Cohort from ≤12 gestational weeks (GW) throughout pregnancy. The frequency of the variant BHMT c.716A allele was 30.8% (95% confidence interval (CI): 28.3, 33.5). In participants with normal-high plasma folate status (>13.4 nmol/L), least square geometric mean [95% CI] plasma dimethylglycine (pDMG, µmol/L) was lower in the GA (2.35 [2.23, 2.47]) versus GG (2.58 [2.46, 2.70]) genotype at ≤12 GW (p < 0.05) and in the GA (2.08 [1.97, 2.19]) and AA (1.94 [1.75, 2.16]) versus GG (2.29 [2.18, 2.40]) genotypes at 15 GW (p < 0.05). No differences in pDMG between genotypes were observed in participants with possible folate deficiency (≤13.4 nmol/L) (p for interactions at ≤12 GW: 0.023 and 15 GW: 0.038). PDMG was lower in participants with the AA versus GG genotype at 34 GW (2.01 [1.79, 2.25] versus 2.44 [2.16, 2.76] and at labour, 2.51 [2.39, 2.64] versus 3.00 [2.84, 3.18], (p < 0.01)). Possible deficiency compared to normal-high folate status was associated with higher pDMG in multiple linear regression analysis (β coefficients [SEM] ranging from 0.07 [0.04], p < 0.05 to 0.20 [0.04], p < 0.001 in models from early and mid-late pregnancy) and the AA compared to GG genotype was associated with lower pDMG (β coefficients [SEM] ranging from −0.11 [0.06], p = 0.055 to −0.23 [0.06], p < 0.001). Conclusion: During pregnancy, the BHMT pathway is affected by folate status and by the variant BHMT c.716A allele.http://www.mdpi.com/2072-6643/8/10/621pregnancyfolatebetaine: homocysteine methyltransferaseBHMT c.716G&gtAbetainedimethylglycine
collection DOAJ
language English
format Article
sources DOAJ
author Jose M. Colomina
Pere Cavallé-Busquets
Sílvia Fernàndez-Roig
Pol Solé-Navais
Joan D. Fernandez-Ballart
Mónica Ballesteros
Per M. Ueland
Klaus Meyer
Michelle M. Murphy
spellingShingle Jose M. Colomina
Pere Cavallé-Busquets
Sílvia Fernàndez-Roig
Pol Solé-Navais
Joan D. Fernandez-Ballart
Mónica Ballesteros
Per M. Ueland
Klaus Meyer
Michelle M. Murphy
Maternal Folate Status and the BHMT c.716G>A Polymorphism Affect the Betaine Dimethylglycine Pathway during Pregnancy
Nutrients
pregnancy
folate
betaine: homocysteine methyltransferase
BHMT c.716G&gt
A
betaine
dimethylglycine
author_facet Jose M. Colomina
Pere Cavallé-Busquets
Sílvia Fernàndez-Roig
Pol Solé-Navais
Joan D. Fernandez-Ballart
Mónica Ballesteros
Per M. Ueland
Klaus Meyer
Michelle M. Murphy
author_sort Jose M. Colomina
title Maternal Folate Status and the BHMT c.716G>A Polymorphism Affect the Betaine Dimethylglycine Pathway during Pregnancy
title_short Maternal Folate Status and the BHMT c.716G>A Polymorphism Affect the Betaine Dimethylglycine Pathway during Pregnancy
title_full Maternal Folate Status and the BHMT c.716G>A Polymorphism Affect the Betaine Dimethylglycine Pathway during Pregnancy
title_fullStr Maternal Folate Status and the BHMT c.716G>A Polymorphism Affect the Betaine Dimethylglycine Pathway during Pregnancy
title_full_unstemmed Maternal Folate Status and the BHMT c.716G>A Polymorphism Affect the Betaine Dimethylglycine Pathway during Pregnancy
title_sort maternal folate status and the bhmt c.716g>a polymorphism affect the betaine dimethylglycine pathway during pregnancy
publisher MDPI AG
series Nutrients
issn 2072-6643
publishDate 2016-10-01
description The effect of the betaine: homocysteine methyltransferase BHMT c.716G>A (G: guanosine; A: adenosine) single nucleotide polymorphism (SNP) on the BHMT pathway is unknown during pregnancy. We hypothesised that it impairs betaine to dimethylglycine conversion and that folate status modifies its effect. We studied 612 women from the Reus Tarragona Birth Cohort from ≤12 gestational weeks (GW) throughout pregnancy. The frequency of the variant BHMT c.716A allele was 30.8% (95% confidence interval (CI): 28.3, 33.5). In participants with normal-high plasma folate status (>13.4 nmol/L), least square geometric mean [95% CI] plasma dimethylglycine (pDMG, µmol/L) was lower in the GA (2.35 [2.23, 2.47]) versus GG (2.58 [2.46, 2.70]) genotype at ≤12 GW (p < 0.05) and in the GA (2.08 [1.97, 2.19]) and AA (1.94 [1.75, 2.16]) versus GG (2.29 [2.18, 2.40]) genotypes at 15 GW (p < 0.05). No differences in pDMG between genotypes were observed in participants with possible folate deficiency (≤13.4 nmol/L) (p for interactions at ≤12 GW: 0.023 and 15 GW: 0.038). PDMG was lower in participants with the AA versus GG genotype at 34 GW (2.01 [1.79, 2.25] versus 2.44 [2.16, 2.76] and at labour, 2.51 [2.39, 2.64] versus 3.00 [2.84, 3.18], (p < 0.01)). Possible deficiency compared to normal-high folate status was associated with higher pDMG in multiple linear regression analysis (β coefficients [SEM] ranging from 0.07 [0.04], p < 0.05 to 0.20 [0.04], p < 0.001 in models from early and mid-late pregnancy) and the AA compared to GG genotype was associated with lower pDMG (β coefficients [SEM] ranging from −0.11 [0.06], p = 0.055 to −0.23 [0.06], p < 0.001). Conclusion: During pregnancy, the BHMT pathway is affected by folate status and by the variant BHMT c.716A allele.
topic pregnancy
folate
betaine: homocysteine methyltransferase
BHMT c.716G&gt
A
betaine
dimethylglycine
url http://www.mdpi.com/2072-6643/8/10/621
work_keys_str_mv AT josemcolomina maternalfolatestatusandthebhmtc716ggtapolymorphismaffectthebetainedimethylglycinepathwayduringpregnancy
AT perecavallebusquets maternalfolatestatusandthebhmtc716ggtapolymorphismaffectthebetainedimethylglycinepathwayduringpregnancy
AT silviafernandezroig maternalfolatestatusandthebhmtc716ggtapolymorphismaffectthebetainedimethylglycinepathwayduringpregnancy
AT polsolenavais maternalfolatestatusandthebhmtc716ggtapolymorphismaffectthebetainedimethylglycinepathwayduringpregnancy
AT joandfernandezballart maternalfolatestatusandthebhmtc716ggtapolymorphismaffectthebetainedimethylglycinepathwayduringpregnancy
AT monicaballesteros maternalfolatestatusandthebhmtc716ggtapolymorphismaffectthebetainedimethylglycinepathwayduringpregnancy
AT permueland maternalfolatestatusandthebhmtc716ggtapolymorphismaffectthebetainedimethylglycinepathwayduringpregnancy
AT klausmeyer maternalfolatestatusandthebhmtc716ggtapolymorphismaffectthebetainedimethylglycinepathwayduringpregnancy
AT michellemmurphy maternalfolatestatusandthebhmtc716ggtapolymorphismaffectthebetainedimethylglycinepathwayduringpregnancy
_version_ 1725253012188823552